ArticleJAMA network open2023

Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan.

Hideki Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.